期刊文献+

lincRNA ULK4P2对肝癌细胞生物学行为的影响

Role of lincRNA ULK4P2 in biological behavior of hepatocellular carcinoma cells
原文传递
导出
摘要 目的通过干扰肝癌细胞株中长链基因间非编码RNA ULK4P2(lincRNA ULK4P2的表达,初步观察lincRNA ULK4P2对肝癌细胞生物学行为的影响。方法运用实时荧光定量聚合酶链反应(RT-qPCR)检测lincRNA ULK4P2在不同肝癌细胞株和正常肝细胞株中的表达,根据RT-qPCR检测结果,选择肝癌细胞株HepG2进行后续干扰实验。将针对lincRNA ULK4P2的小干扰RNA(siRNA)序列,包括siRNA-1、siRNA-2、siRNA-3、siRNA-mock(空白对照)、siRNA-Scramble(将目的 siRNA序列打乱后重新组合所得的阴性对照)转染HepG2细胞,根据转染序列siRNA后对HepG2细胞lincRNA ULK4P2的干扰效果,选择siRNA-2进行之后的功能检测。应用siRNA下调HepG2细胞中lincRNA ULK4P2的表达,运用CCK-8技术研究lincRNA ULK4P2表达下降对肝癌细胞增殖情况的影响,运用流式细胞仪检测lincRNA ULK4P2表达下降对肝癌细胞凋亡和细胞周期分布的影响。对CCK-8实验中siRNA-2组、siRNA-mock组和siRNA-Scramble组HepG2细胞增殖活性(吸光度)的比较采用单因素方差分析。对分别转染siRNA-2、siRNA-mock、siRNA-Scramble的HepG2细胞通过流式细胞仪检测所得细胞周期分布情况,采用单因素方差分析。结果 CCK-8实验显示,与siRNA-mock组和siRNA-Scramble组比较,siRNA-2组HepG2细胞在转染后72 h增殖活性明显下降,差异具有统计学意义(P <0.05)。下调HepG2细胞lincRNA ULK4P2的表达后,细胞各个周期时相中细胞数目无明显变化;siRNA-2组HepG2细胞中G2/M期细胞的比例(43.92%)相对于siRNA-mock组(7.81%)和siRNA-Scramble组(8.21%)明显上升,差异具有统计学意义(P<0.05)。结论 lincRNA ULK4P2可能参与了肝癌细胞增殖和细胞周期的分子调控过程。 Objective To investigate the role of the long-strand intergenic non-coding RNA(lincRNA)ULK4P2 in the biological behavior of hepatocellular carcinoma cells by interfering with the expression of lincRNA ULK4P2 in hepatocellular carcinoma cell lines.Methods Real-time quantitative polymerase chain reaction(RT-qPCR)was used to detect the expression of lincRNA ULK4P2 in different hepatoma cell lines and normal cells.According to the results of RT-qPCR,hepatocellular carcinoma cell line HepG2 was selected for subsequent interference experiments.Small interfering RNA(siRNA)targeting lincRNA ULK4P2,including siRNA-1,siRNA-2,and siRNA-3,as well as siRNA-mock(blank control)and siRNA-Scramble(reconstructed after shuffling the siRNA sequence of interest;negative control)were transfected into HepG2 cells,and siRNA-2 was selected for subsequent experiments according to the interference effect on lincRNA ULK4P2.The expression of lincRNA ULK4P2 in HepG2 cells was downregulated by siRNA-mediated interference.The role of lincRNA ULK4P2 expression in the proliferation of hepatoma cells was studied by CCK-8 assay.Flow cytometry was used to detect the expression of lincRNA ULK4P2 and the influence on apoptosis and cell cycle distribution of liver cancer cells.One-way analysis of variance was used to compare the proliferation activity(absorbance)and cell cycle distribution of HepG2 cells transfected with siRNA-2,siRNA-mock,or siRNA-Scramble.Results Compared with the siRNA-mock group and siRNA-Scramble group,the proliferation of hepatocellular carcinoma cells was significantly inhibited after the down-regulation of lincRNA ULK4P2 in the siRNA-2 group(P<0.05).After downregulating the expression of lincRNA ULK4P2 in HepG2 cells,there was no significant change in the number of cells in each phase.The proportion of G2/M phase cells in the siRNA-2 group(43.92%)was significantly higher than that in the siRNA-mock group(7.81%)and siRNA-Scramble group(8.21%)(P<0.05).Conclusion Our findings indicate that lincRNA ULK4P2 may be involved in the proliferation of hepatocellular carcinoma cells.
作者 余婷婷 陈飞 杨宏山 李俊 Yu Tingting;Chen Fei;Yang Hongshan;Li Jun(Department of Oncology,Xiaogan Hospital Affiliated to Wuhan University of Science and Technology,Xiaogan 432000,China)
出处 《中华临床医师杂志(电子版)》 CAS 2018年第8期456-461,共6页 Chinese Journal of Clinicians(Electronic Edition)
关键词 长链基因间非编码RNAULK4P2 肝癌 作用机制 Long intergenic non-coding RNA ULK4P2 Hepatocellular carcinoma Mechanism
  • 相关文献

参考文献1

二级参考文献30

  • 1Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, Zhu N, ZhouWP, Yang GS, Wang YZ, Shang JL, Gao CF, Zhang FR, Wang F,Sun SH. Long noncoding RNA high expression in hepatocellularcarcinoma facilitates tumor growth through enhancer of zestehomolog 2 in humans. Hepatology 2011; 54: 1679-1689 [PMID:21769904 DOI: 10.1002/hep.24563].
  • 2El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiologyand molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576 [PMID: 17570226].
  • 3Chang MH. Cancer prevention by vaccination against hepatitis B.Recent Results Cancer Res 2009; 181: 85-94 [PMID: 19213561].
  • 4Szymanski M, Barciszewska MZ, Erdmann VA, Barciszewski J.A new frontier for molecular medicine: noncoding RNAs. BiochimBiophys Acta 2005; 1756: 65-75 [PMID: 16125325 DOI: 10.1016/j.bbcan.2005.07.005].
  • 5Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs:insights into functions. Nat Rev Genet 2009; 10: 155-159 [PMID:19188922 DOI: 10.1038/nrg2521].
  • 6Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T,Horvitz HR, Golub TR. MicroRNA expression profiles classify humancancers. Nature 2005; 435: 834-838 [PMID: 15944708].
  • 7Prensner JR, Chinnaiyan AM. The emergence of lncRNAs incancer biology. Cancer Discov 2011; 1: 391-407 [PMID: 22096659DOI: 10.1158/2159-8290.CD-11-0209].
  • 8Ponting CP, Oliver PL, Reik W. Evolution and functions of longnoncoding RNAs. Cell 2009; 136: 629-641 [PMID: 19239885 DOI:10.1016/j.cell.2009.02.006].
  • 9Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs:functional surprises from the RNA world. Genes Dev 2009; 23:1494-1504 [PMID: 19571179 DOI: 10.1101/gad.1800909].
  • 10Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprintedgene contribution in tumorigenesis. Int J Cancer 2011; 129: 773-779[PMID: 21400503 DOI: 10.1002/ijc.26052].

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部